– Alignment achieved with U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA) and Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) for EMPEROR – – One-year study of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback